glp 1 oral tablets FDA Approved: Orforglipron (Foundayo) — GLP-1 Drug • FDA approved for chronic weight management • Indicated for obesity and overweight with comorbidities • Oral, once-daily GLP-1 receptor agonist • First non-peptide Novo Nordisk's Wegovy® pill, the

Regular aerobic exercise improves cerebral blood flow, promotes neuroplasticity, reduces inflammation, and enhances mood

A 2022 JAMA study on 338 adults who had overweight or obesity found that taking semaglutide and liraglutide, respectively, led to an average 15.8% and 6.4% loss in body weight over 68 weeks

4 GLP-1R clinical trial progress 4.1 GLP-1R agonists in the treatment of DM GLP-1R agonists have emerged as a significant therapeutic agent in the management of diabetes

GLP-1 receptors can be found throughout the body most importantly for our purposes, in the GI tract, pancreas, and brain

Remember, small, consistent changes in your eating habits can lead to significant long-term improvements in your metabolic health and quality of life

Asmar, P.K